Ulta Beauty, Inc. (ULTA) Stock Analysis
Is ULTA a good investment?
Ulta Beauty, Inc. (ULTA) has a Plutrex AI rating of 46.0/100 as of November 08, 2026, indicating a Hold consensus. The stock is halal-compliant per AAOIFI standards. Key strength: Exceptional capital efficiency: ROE 46.1% is 102% above the industry average of 22.79%, combined with $1.067B annual FCF — the strongest quantitative justification for any quality premium in valuation. Main concern: Severe valuation overextension (WORSENED): PEG 2.04x (vs. industry 0.984x — a 107% premium); analyst target $646.62 implies only 0.3% upside vs. current price $644.76; stock rose +3.3% since prior report while targets held flat, further compressing entry math — fair value at PEG 1.5x remains near $474-$510, implying 20-26% downside from current levels.
Investment Summary
ULTA Beauty is a high-quality specialty retailer trading at a materially unjustified valuation premium. At $644.76, the stock carries a P/E of 23.49x against 5-year forward EPS growth of only 11.52% — producing a PEG of 2.04x, which is 107% above the industry average PEG of 0.984x. Analyst consensus target of $646.62 implies essentially zero upside (0.3%). The company's fundamentals are genuinely strong: ROE of 46.1% is more than double the industry average of 22.79%; FCF of $1.067B provides robust self-funding capacity; operating margin of 12.51% beats the industry average of 10.58% by 182 bps. However, 5-year forward EPS growth of 11.52% lags the industry average of 26.21% by 56%, and revenue growth of 8.9% trails peers at 12.64%. News sentiment is elevated at 91.9/100 with headlines suggesting analysts expect another earnings beat and positive long-term positioning, but the news cycle is largely supportive rather than transformative. The stock has risen another +3.3% since the prior report ($624.46 → $644.76) while analyst targets held flat at $646.62, further compressing the already minimal upside. VALUATION DOMINATES — HOLD existing positions; DO NOT initiate new positions at current price.
Key Strengths
- Exceptional capital efficiency: ROE 46.1% is 102% above the industry average of 22.79%, combined with $1.067B annual FCF — the strongest quantitative justification for any quality premium in valuation
- Near-term EPS resilience: Forward 1-year EPS growth of 10.91% dramatically outperforms an industry average of -4.55% — ULTA is growing earnings while the average specialty retailer faces contraction, supporting relative defensive quality
- Positive analyst and news momentum: News sentiment 91.9/100 with headlines including 'Will Ulta Beat Estimates Again?' and 'Why Ulta Beauty is a Top Stock for the Long-Term' suggest analyst community remains constructive and earnings surprise potential exists near-term
Key Concerns
- Severe valuation overextension (WORSENED): PEG 2.04x (vs. industry 0.984x — a 107% premium); analyst target $646.62 implies only 0.3% upside vs. current price $644.76; stock rose +3.3% since prior report while targets held flat, further compressing entry math — fair value at PEG 1.5x remains near $474-$510, implying 20-26% downside from current levels
- Structural long-term growth lag (UNCHANGED): 5-year forward EPS growth 11.52% is 56% below the industry average of 26.21%; revenue growth 8.9% trails industry average 12.64% by 30% — ULTA is a mature compounder paying a growth-company multiple without the growth rate to justify it, creating asymmetric downside risk if consumer spending softens or execution disappoints
Plutrex 10-Factor AI Breakdown
Fundamental Analysis
Profitability is ULTA's undeniable crown: ROE of 46.1% (vs. industry average 22.79%, a +102% premium), operating margin 12.51% (vs. industry 10.58%), net margin 9.34% (below industry 11.39% — a notable drag), and gross margin 39.32% (below industry 41.76%). FCF of $1.067B is exceptional for a specialty retailer and provides real-world validation of earnings quality. Financial health is mixed: Debt-to-Equity of 0.71 is 74% above the industry average of 0.408, and cash of $213M is lean for the company's scale, though FCF buffers both concerns significantly. Growth is decelerating: YoY EPS growth 5.2% lags the historical rate of 13.3%; next-year EPS growth projected at 10.9% and 5-year at 11.52% — the latter being 56% below the industry average of 26.21%. Revenue growth of 8.9% trails the industry average of 12.64% by ~30%. Valuation is the critical failure: PEG 2.04x (vs. industry 0.984x); P/E 23.49x for ~11.5% growth implies fair-value P/E should be ~11.5-13x (at PEG 1.0-1.1), suggesting intrinsic value of $315-$360 by value-investing standards. Even at a generous PEG of 1.5x (quality premium for ROE/FCF), justified P/E = ~17.3x, implying fair value near $474 — roughly 26% below current price.
News Sentiment
Ulta Beauty is riding a wave of positive analyst attention even as the stock hovers near all-time highs — but Wall Street's enthusiasm comes with a catch. The beauty retail giant, which operates over 1,350 stores across the United States, is generating buzz across financial media with headlines like 'Wall Street Analysts See Ulta as a Buy: Should You Invest?' and 'Why Ulta Beauty is a Top Stock for the Long-Term,' painting a picture of a company still viewed favorably by the professional investment community. Perhaps most intriguingly, analysts are circling an upcoming earnings report with real anticipation. A deep dive using Zacks Earnings ESP methodology — a statistical tool for predicting earnings surprises — suggests the company has 'key ingredients for another earnings beat,' which would continue ULTA's impressive track record of outperforming Wall Street expectations. On the business front, a new partnership with fitness wearable company WHOOP aims to reach millions of consumers, potentially tapping into the intersection of wellness and beauty — a fast-growing segment. Meanwhile, the broader shift toward clean beauty products represents both a challenge and an opportunity, requiring ULTA to actively expand and curate its clean beauty assortment to stay ahead of changing consumer preferences. The bottom line: Analysts remain constructive on ULTA's near-term prospects, and the company continues to innovate. But with the stock priced for near-perfection at $644 and analyst targets barely above current levels, the room for error is razor-thin.
Risk Assessment
PRIMARY RISK: Valuation compression. At PEG 2.04x vs. industry 0.984x, any earnings disappointment or multiple de-rating toward the industry norm would imply 40-50% downside. The lean analyst upside of 0.3% provides no cushion. SECONDARY RISK: Structural growth deceleration — 5-year EPS growth 11.52% vs. industry 26.21% means peers are expected to close the gap materially over the next 3-5 years, reducing ULTA's quality premium justification over time. NEAR-TERM CATALYST RISK: Positive news cycle (91.9/100 sentiment) could sustain elevated prices longer than fundamental math suggests, but this creates binary risk around earnings — any miss would trigger rapid multiple compression. MITIGATION: Existing holders should maintain positions with stop at $590 (prior support); new money should wait for entry zone $510-$545 where PEG drops to approximately 1.5-1.6x and risk/reward improves materially. UPSIDE SCENARIO: If 5-year EPS growth accelerates toward 15%+ (clean beauty expansion, WHOOP partnership driving new customer acquisition), justified PEG of 1.5x would support $650+ — but this is not the base case.
Related Halal Stocks
Related Stocks
Frequently Asked Questions
Is ULTA a halal stock?
Yes, Ulta Beauty, Inc. (ULTA) is halal-compliant per AAOIFI standards as of the latest quarterly review.
What is Plutrex's AI rating for ULTA?
Ulta Beauty, Inc. (ULTA) has a Plutrex AI rating of 46.0/100 with a Hold consensus, based on a 10-factor analysis covering financial health, growth, valuation, profitability, debt, analyst sentiment, technical momentum, insider confidence, news sentiment, and halal compliance.
Is ULTA a good investment?
According to Plutrex AI, ULTA has a Hold rating (46.0/100). For the full analysis including trading plan and risk assessment, see the detailed breakdown above.
How can I invest in ULTA?
US stocks like ULTA can be bought through international brokers such as Interactive Brokers, accessible to Arab investors. ElBarake provides comprehensive analysis plus AI-generated trading plans with entry points, stop losses, and profit targets.
What are the main risks of investing in ULTA?
Plutrex AI identifies the main risks for ULTA by analyzing valuation, debt, market sentiment, and macro factors. See the Risk Assessment section above for the full breakdown.